Navigation Links
New Clinical Studies Presented at the American Society of Anesthesiology (ASA) Annual Meeting Show Masimo Technologies Provide Advanced Clinical Intelligence
Date:10/23/2008

Masimo's Commercial Exhibit Draws More Than 2,500 Conference Attendees

IRVINE, Calif., Oct. 23 /PRNewswire-FirstCall/ -- Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that 13 new independent and objective clinical studies presented at the American Society of Anesthesiology (ASA) Annual Meeting in Orlando, Fla., October 19-21, 2008, found Masimo SET(R) and Masimo Rainbow SET(R) technologies to be crucial in providing clinicians with an early indication of their patients' deteriorating health status in numerous clinical settings, which may allow earlier intervention and prevention of adverse clinical outcomes.

In addition, Masimo's commercial exhibit attracted over 2,500 anesthesiologists from the U.S. and around the world. Anesthesiologists visiting the commercial exhibit marveled at Masimo noninvasive hemoglobin (SpHb(TM)), the first-and-only technology capable of continuously monitoring hemoglobin status. Continuous monitoring of anemic status with Masimo SpHb may allow clinicians to make earlier and better treatment decisions, such as detecting blood loss earlier to initiate more timely transfusions in some patients and avoiding unnecessary blood transfusions in others.

Select Clinical Study Highlights

Continuous Pulse Ox Impacts Early Detection of Physiological Abnormalities in Post-Surgical Patients(1), a clinical evaluation led by Dr. George Blike at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire, compared clinical data, patient outcomes and nursing satisfaction before and after implementation of Masimo Patient SafetyNet(TM) -- a remote monitoring and wireless clinician notification system -- on a 36-bed post-surgical care unit. Findings during the three-month evaluation -- covering 2,587 total patient days -- showed an 80 percent decrease in distress codes and rescue activations, and a 50 percent decrease in ICU transfers for Masimo Pati
'/>"/>

SOURCE Masimo Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
6. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
9. Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia
10. YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer
11. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)..., SCHIEDLBERG, Austria, November 9 /PRNewswi... the world have been working on the development of...t communication channel,between the brain and a co...,patients to communicate or to control devices in ...the last years some patients have been supervised ...
(Date:11/9/2009)... Product release is a resea...ubjects, research facilities and research safety s...n. , Cedar Knolls, NJ (PR...nounced today that it has unveiled Pristima™...r research facilities that track the use and care ...
(Date:11/6/2009)..., TORONTO, Nov. 6 /PRNewswire-FirstCall/ - Micro...y that it has re-filed the Form 52-109F1 Certifica...f Executive Officer and James Long, the Chief Fina... January 12, 2009 in connection with the annual au...ember 30, 2008. ,, The Company initially filed ...
(Date:11/6/2009)..., SAN MATEO, Calif., Nov. 6 /PRNewswire-FirstCal... Completed transfer of Qutenza(TM) E.U. Marketing ...e significant progress in commercial readiness act...les; Senior Director, Marketing; and Director, Com...to board as director and Audit Committee chairman ...
Breaking Biology Technology:intendiX - Communication by Thoughts: First Patient-Ready System on the Market 2Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10
...y of grant-winning ability, the University of Wis... National Science Foundation to address some of t...change. , ,The NSF grants, coupled with matching i...ost to the university,s graduate study and researc...onmental protection. , ,The two $3 million grants...
...ng of new products, or simply the last rush to get...ay was a busy day for product news. In fact, two D...tive newcomer Streamload - are delivering signif...s. , ,In the case of Palm, it is the Treo 700p sma...based on a lovely new implementation of the Palm O...
...holder lawsuits alleging violations of federal sec...nologies, Inc. has accepted the resignation of co...rtimore, who founded the company and served as its...en appointed as the company,s interim CEO. Mike Du... named chairman of the board of directors, succeed...
Other Biology Technology:NSF grants bolster integrative graduate study at UW-Madison 2Two DEMO alumni make big product splashes 2Two DEMO alumni make big product splashes 3Merge president steps down in wake of shareholder suits 2Merge president steps down in wake of shareholder suits 3
(Date:11/6/2009)...A (November 06, 2009) The Monell Center and the C...he Beijing International Meeting on Taste and Smel...ith the CAS, the meeting will be the first interna...ina. , Alan Leshner, Chief Executive Officer, Am...and Executive Publisher of Science magazine, will ...
(Date:11/5/2009)...Conn.Researchers at Yale University have developed...,s immune response to HIV and HIV-infected cells, ...s, published online in the Journal of the America...ic approaches for these diseases. , The molecul... HIV" (ARM-H) and "antibody-recruiting molecule ta...
(Date:11/4/2009)...A Although scientists are reluctant to officially...evidence continues to grow about its protective ef...in Cancer Prevention Research , a journal of the ...ggests some reduction in oral cancer. , Vassili... in the Department of Thoracic/Head and Neck Medic...
Breaking Biology News(10 mins):Monell Center joins with CAS to host Beijing meeting on taste and smell research 2New synthetic molecules trigger immune response to HIV and prostate cancer 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2SpectraScience Engages European Contract Research Organization to Manage Clinical Trials 14457 1SpectraScience Engages European Contract Research Organization to Manage Clinical Trials 14457 2SpectraScience Engages European Contract Research Organization to Manage Clinical Trials 14457 3Global Bioenergies is Setting Up its Scientific Advisory Board and Obtains Proof of Concept for a Bioprocess Generating Gaseous Hydrocarbons From Rene 14455 1Global Bioenergies is Setting Up its Scientific Advisory Board and Obtains Proof of Concept for a Bioprocess Generating Gaseous Hydrocarbons From Rene 14455 2Amylin Pharmaceuticals to Webcast Third Quarter Results 14453 1Amylin Pharmaceuticals to Webcast Third Quarter Results 14453 2
...roinformatics will convene September 7-9 at the St...merging neuroinformatics field combines neuroscien...ols and approaches to understanding the structure ...pplied to brain disorders and diseases. With a bro...together experts from all disciplines contributing...
... a sophisticated computer model pioneered at Princ...ound that many governments worldwide are recommend...e the availability of many drugs and therapies to ...ecommend using what is known as a single first-lin...th many patients. Writing in the Sept. 16 issue of...
...eding colonies of a critically endangered vulture,... of millions to a few thousand, are too small to p...f Michigan analysis shows. , Adding wild birds to...ia, is crucial, but political and logistical barri.... Johnson. , The study was published online Augus...
Other Biology News:INCF organizes the first congress dedicated to the emerging field of neuroinformatics 2Best way to treat malaria: Avoid using same drug for everyone, scientists say 2Best way to treat malaria: Avoid using same drug for everyone, scientists say 3Recovery efforts not enough for critically endangered Asian vulture 2Recovery efforts not enough for critically endangered Asian vulture 3
...aratus is used to screen blots of mini format (8 x...ferent antibodies or sera without having to cut th...plate, 2 separate, detachable sample templates tha...askets and clamps that secure the blots to form 40...
...ion of SYBR Green I or FAM in the first channel, a...including TET, HEX, VIC, and TAMRA for a multitud...rimination. DNA Engine thermal cycler offers preci...ature permits simultaneous incubation at 12 differ...
Fingerprinting II Database Sharing Tools from Bio-Rad
Fingerprinting II Dimensioning Techniques from Bio-Rad
Biology Products: